Stocks · Korea
038530
KOSDAQ
Kbio Labs
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+4.44%
1M-22.32%
3M-5.25%
6M-55.78%
1Y-40.99%
YTD-35.87%
52W high13,750원
52W low—
From 52W high-71.78%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 336억 | -2억 | -77억 | -0.5% |
| 2023 | 273억 | -6억 | -127억 | -2.0% |
| 2024 | 765억 | 8억 | -100억 | 1.0% |
| 2025 | 873억 | 15억 | -50억 | 1.7% |
| Quarterly | ||||
| 2024 4Q | 249억 | 14억 | -153억 | 5.8% |
| 2025 1Q | 205억 | 3억 | 47,995,377원 | 1.7% |
| 2025 2Q | 208억 | 9,281,337원 | -33억 | 0.0% |
| 2025 3Q | 176억 | -1억 | -1억 | -0.7% |
| 2025 4Q | 284억 | 13억 | -16억 | 4.6% |
| 2026 1Q | 159억 | -8억 | 23억 | -5.1% |
Company
Address: 서울특별시 강동구 올림픽로 834 206호(암사동, 한강시티라이프)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-07-06주요사항보고서(유상증자결정) Major
- 2026-05-15분기보고서 (2026.03)
- 2026-05-15[기재정정]분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.